ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines
![EMA EMA](/images/logo/ema.png)
European Medicines Agency (EMA) News Channel
In reaching its conclusion, the committee took into consideration all currently available evidence, including the advice from an ad hoc expert group.